Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.

Boisseau W, Euskirchen P, Mokhtari K, Dehais C, Touat M, Hoang-Xuan K, Sanson M, Capelle L, Nouet A, Karachi C, Bielle F, Guégan J, Marie Y, Martin-Duverneuil N, Taillandier L, Rousseau A, Delattre JY, Idbaih A.

Oncologist. 2019 Jul 25. pii: theoncologist.2019-0223. doi: 10.1634/theoncologist.2019-0223. [Epub ahead of print]

PMID:
31346129
2.

Management of meningioma.

Euskirchen P, Peyre M.

Presse Med. 2018 Nov - Dec;47(11-12 Pt 2):e245-e252. doi: 10.1016/j.lpm.2018.05.016. Epub 2018 Nov 16. Review.

PMID:
30449639
3.

Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.

Euskirchen P, Radke J, Schmidt MS, Schulze Heuling E, Kadikowski E, Maricos M, Knab F, Grittner U, Zerbe N, Czabanka M, Dieterich C, Miletic H, Mørk S, Koch A, Endres M, Harms C.

PLoS One. 2017 Sep 25;12(9):e0185376. doi: 10.1371/journal.pone.0185376. eCollection 2017.

4.

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.

Euskirchen P, Bielle F, Labreche K, Kloosterman WP, Rosenberg S, Daniau M, Schmitt C, Masliah-Planchon J, Bourdeaut F, Dehais C, Marie Y, Delattre JY, Idbaih A.

Acta Neuropathol. 2017 Nov;134(5):691-703. doi: 10.1007/s00401-017-1743-5. Epub 2017 Jun 21.

5.

Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in Glioblastoma.

Schulze Heuling E, Knab F, Radke J, Eskilsson E, Martinez-Ledesma E, Koch A, Czabanka M, Dieterich C, Verhaak RG, Harms C, Euskirchen P.

Mol Cancer Res. 2017 May;15(5):532-540. doi: 10.1158/1541-7786.MCR-16-0322. Epub 2017 Feb 1.

6.

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Välk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Leiss L, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PØ, Winkler F, Ritter CA, Niclou SP, Watts C, Bjerkvig R, Miletic H.

Neuro Oncol. 2016 Dec;18(12):1644-1655. Epub 2016 Jun 10. Erratum in: Neuro Oncol. 2016 Dec;18(12 ):e2.

7.

Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.

Dzaye O, Hu F, Derkow K, Haage V, Euskirchen P, Harms C, Lehnardt S, Synowitz M, Wolf SA, Kettenmann H.

J Neuropathol Exp Neurol. 2016 May;75(5):429-40. doi: 10.1093/jnen/nlw016. Epub 2016 Mar 30.

8.

Complete remission of critical neurohistiocytosis by vemurafenib.

Euskirchen P, Haroche J, Emile JF, Buchert R, Vandersee S, Meisel A.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 26;2(2):e78. doi: 10.1212/NXI.0000000000000078. eCollection 2015 Apr.

9.

Sporadic Creutzfeldt-Jakob disease with mesiotemporal hypermetabolism.

Euskirchen P, Buchert R, Koch A, Schulz-Schaeffer WJ, Schreiber SJ, Sobesky J.

J Neurol Sci. 2014 Oct 15;345(1-2):278-80. doi: 10.1016/j.jns.2014.07.054. Epub 2014 Aug 1. No abstract available.

PMID:
25115503
10.

Corticosteroids alter CGRP and melatonin release in cluster headache episodes.

Neeb L, Anders L, Euskirchen P, Hoffmann J, Israel H, Reuter U.

Cephalalgia. 2015 Apr;35(4):317-26. doi: 10.1177/0333102414539057. Epub 2014 Jun 23.

PMID:
24958681
11.

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.

Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Sakariassen PØ, Eskilsson E, Stieber D, Keunen O, Brekka N, Moen I, Nigro JM, Vintermyr OK, Lund-Johansen M, Niclou S, Mørk SJ, Enger PO, Bjerkvig R, Miletic H.

Acta Neuropathol. 2013 May;125(5):683-98. doi: 10.1007/s00401-013-1101-1. Epub 2013 Feb 22.

12.

NUMB does not impair growth and differentiation status of experimental gliomas.

Euskirchen P, Skaftnesmo KO, Huszthy PC, Brekkå N, Bjerkvig R, Jacobs AH, Miletic H.

Exp Cell Res. 2011 Dec 10;317(20):2864-73. doi: 10.1016/j.yexcr.2011.09.002. Epub 2011 Sep 12.

PMID:
21939656
13.

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.

Huszthy PC, Giroglou T, Tsinkalovsky O, Euskirchen P, Skaftnesmo KO, Bjerkvig R, von Laer D, Miletic H.

PLoS One. 2009 Jul 20;4(7):e6314. doi: 10.1371/journal.pone.0006314.

Supplemental Content

Loading ...
Support Center